Tandem Diabetes Care TNDM Intangible costs in other long-term liabilities
Intangible costs in other long-term liabilities at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept tndm:IntangibleCostsInOtherCurrentAndOtherLongTermLiabilities.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's intangible costs in other long-term liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's intangible costs in other long-term liabilities?
- Tandem Diabetes Care (TNDM) reported intangible costs in other long-term liabilities of $13.3M in Q1 2026.
- What does intangible costs in other long-term liabilities mean?
- This metric tracks costs associated with intangible assets that are capitalized and recorded within non-current or current liability accounts rather than immediate cash outflows. It often relates to deferred payments or obligations arising from the acquisition of intellectual property or licensing rights. Monitoring this helps investors identify future cash commitments related to the company's intangible asset portfolio.